Synthesis, antimicrobial, and anti-inflammatory activity, of novel S-substituted and N-substituted 5-(1-adamantyl)-1,2,4-triazole-3-thiols

References

• Lamoureux G Artavia G Use of the adamantane structure in medicinal chemistry Curr Med Chem 2010 17 2967 2978 20858176
   PubMed Web of Science ®Google Scholar
• Liu J Obando D Liao V Lifa T Codd R The many faces of the adamantyl group in drug design Eur J Med Chem 2011 46 1949 1963 21354674
   PubMed Web of Science ®Google Scholar
• Davies WL Grunnert RR Haff RF Antiviral activity of 1-adamantamine (amantadine) Science 1964 144 862 863 14151624
   PubMed Web of Science ®Google Scholar
• Wendel HA Snyder MT Pell S Trial of amantadine in epidemic influenza Clin Pharmacol Ther 1966 7 38 43 5325584
   PubMed Web of Science ®Google Scholar
• Togo Y Hornick RB Dawkins AT Studies on induced influenza in man. I. Double blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against A2/Rockville/1/65 strain JAMA 1968 203 1089 1094 4868123
   PubMed Web of Science ®Google Scholar
• Hayden FG Gwaltney JMJr Van der Castle RL Adams KF Giordani B Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults Antimicrob Agents Chemother 1981 19 226 233 7347558
   PubMed Web of Science ®Google Scholar
• Ilyushina NA Bovin NV Webster RG Govorkova EA Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants Antiviral Res 2006 70 121 131 16516984
   PubMed Web of Science ®Google Scholar
• Tilley JW Levitan P Kramer MJ Adamantyl thiourea derivatives as antiviral agents J Med Chem 1979 22 1009 1010 490532
   PubMed Web of Science ®Google Scholar
• Pérez-Pérez MJ Balzarini J Hosoya M De Clercq E Camarasa MJ Synthesis of adamantane-spirosultones as potential antiviral agents Bioorg Med Chem Lett 1992 2 647 648
   Web of Science ®Google Scholar
• Zoidis G Fytas C Papanastasiou I Heterocyclic rimantadine analogues with antiviral activity Bioorg Med Chem 2006 14 3341 3348 16439137
   PubMed Web of Science ®Google Scholar
• Van Derpoorten K Balzarini J De Clercq E Poupaert JH Anti-HIV activity of N-1-adamantyl-4-aminophthalimide Biomed Pharmacother 1997 51 464 468 9863507
   PubMed Web of Science ®Google Scholar
• Balzarini J Orzeszko B Mauri JK Orzeszko A Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones Eur J Med Chem 2007 42 993 1003 17321639
   PubMed Web of Science ®Google Scholar
• El-Emam AA Al-Deeb OA Al-Omar MA Lehmann J Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones Bioorg Med Chem 2004 12 5107 5113 15351394
   PubMed Web of Science ®Google Scholar
• Villhauer EB Brinkman JA Naderi GB 1-(3-Hydroxy-1-adamantyl)aminoacetyl-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties J Med Chem 2003 46 2774 2789 12801240
   PubMed Web of Science ®Google Scholar
• Wang JJ Wang SS Lee CF Chung MA Chern YT In vitro antitumor and antimicrobial activity of N-substituents of maliemide by adamantane and diamantane Chemotherapy 1997 43 182 189 9142459
   PubMed Web of Science ®Google Scholar
• Antoniadou-Vyza E Tsitsa P Hytiroglou E Tsantili-Kakoulidou A New adamantan-2-ol and adamantan-1-methanol derivatives as potent antibacterials, synthesis, antibacterial activity and lipophilicity studies Eur J Med Chem 1996 31 105 110
   Web of Science ®Google Scholar
• Omar K Geronikaki A Zoumpoulakis P Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs Bioorg Med Chem 2010 18 426 432 19914077
   PubMed Web of Science ®Google Scholar
• Jia L Tomaszewski JE Hanrahan C Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug Br J Pharmacol 2005 144 80 87 15644871
   PubMed Web of Science ®Google Scholar
• Brown JR North EJ Hurdle JG The structure-activity relationship of urea derivatives as anti-tuberculosis agents Bioorg Med Chem 2011 19 5585 5595 21840723
   PubMed Web of Science ®Google Scholar
• El-Emam AA Al-Tamimi A-MS Al-Omar MA Al-Rashood KA Habib EE Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminomethyl-4-substituted-1,2,4-triazoline-3-thiones Eur J Med Chem 2013 68 96 102 23973821
   PubMed Web of Science ®Google Scholar
• Al-Deeb OA Al-Omar MA El-Brollosy NR Habib EE Ibrahim TM El-Emam AA Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-[3-(1-adamantyl)-4-substituted-5-thioxo-1,2,4-triazolin-1-yl]acetic acids, 2-[3-(1-adamantyl)-4-substituted-5-thioxo-1,2, 4-triazolin-1-yl]propionic acids and related derivatives Arzneimittelforschung 2006 56 40 47 16478004
   PubMed Web of Science ®Google Scholar
• Kadi AA El-Brollosy NR Al-Deeb OA Habib EE Ibrahim TM El-Emam AA Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles Eur J Med Chem 2007 42 235 242 17129641
   PubMed Web of Science ®Google Scholar
• Al-Omar MA Al-Abdullah ES Shehata IA Habib EE Ibrahim TM El-Emam AA Synthesis, antimicrobial, and anti-inflammatory activities of novel 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles and related derivatives Molecules 2010 15 2526 2550 20428062
   PubMed Web of Science ®Google Scholar
• El-Emam AA Ibrahim TM Synthesis, anti-inflammatory and analgesic activity of certain 3-(1-adamantyl)-4-substituted-5-mercapto-1,2, 4-triazole derivatives Arzneimittelforschung 1991 41 1260 1264 1815527
   PubMed Web of Science ®Google Scholar
• Kouatly O Geronikaki A Kamoutsis C Hadjipavlou-Litina D Eleftheriou P Adamantane derivatives of thiazolyl-N-substituted amide, as possible non-steroidal anti-inflammatory agents Eur J Med Chem 2009 44 1198 1204 18603333
   PubMed Web of Science ®Google Scholar
• Baxter A Bent J Bowers K Hit-to-lead studies: the discovery of potent adamantane amide P2X7 receptor antagonists Bioorg Med Chem Lett 2003 13 4047 4050 14592505
   PubMed Web of Science ®Google Scholar
• Schwab RS England ACJr Poskanzer DC Young RR Amantadine in the treatment of Parkinson’s disease JAMA 1969 208 1168 1170 5818715
   PubMed Web of Science ®Google Scholar
• Abou-Gharbia MA Childers WE Fletcher H Synthesis and SAR of adatanserin: novel adamantly aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents J Med Chem 1999 42 5077 5094 10602693
   PubMed Web of Science ®Google Scholar
• Bormann J Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels Eur J Pharmacol 1989 166 59l 592
   Web of Science ®Google Scholar
• Chai X Zhang J Yu S Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols Bioorg Med Chem Lett 2009 19 1811 1814 19231179
   PubMed Web of Science ®Google Scholar
• Xu J Cao Y Zhang J Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives Eur J Med Chem 2011 46 3142 3148 21420761
   PubMed Web of Science ®Google Scholar
• Karthikeyan MS Prasad DJ Boojary B Bhat KS Holla BS Kumari NS Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5-fluorphenyl moiety Bioorg Med Chem 2006 14 7482 7489 16879972
   PubMed Web of Science ®Google Scholar
• Almajan GL Barbuceanu SF Almajan E Draghici C Saramet G Synthesis, characterization and antibacterial activity of some triazole Mannich bases carrying diphenylsulfone moieties Eur J Med Chem 2009 44 3083 3089 18708273
   PubMed Web of Science ®Google Scholar
• Wade PC Vogt BR Kissick TP Simpkins LM Palmers DM 1-Acyltriazoles as anti-inflammatory agents J Med Chem 1982 25 331 333 6461764
   PubMed Web of Science ®Google Scholar
• Tozkoparan B Küpeli E Yeşilada E Ertan M Preparation of 5-aryl-3-alkylthio-l,2,4-triazoles and corresponding sulfones with anti-inflammatory-analgesic activity Bioorg Med Chem 2007 15 1808 1814 17166724
   PubMed Web of Science ®Google Scholar
• Navidpour L Shafaroodi H Abdi K Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors Bioorg Med Chem 2006 14 2507 2517 16337127
   PubMed Web of Science ®Google Scholar
• Al-Abdullah ES Shehata IA Al-Deeb OA El-Emam AA Microwave-assisted dehydrosulphurization: an efficient, solvent-free synthesis of 5-(1-adamantyl)-2-arylamino-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles Heterocycles 2007 71 379 388
   Web of Science ®Google Scholar
• El-Emam AA Al-Tamimi AMS Al-Rashood KA Structural and spectroscopic characterization of a novel potential chemotherapeutic agent 3-(1-Adamantyl)-1-{[4-(2-methoxyphenyl)piperazin-1-yl] methyl}-4-methyl-1H-1,2,4-triazole-5(4H)-thione by first principle calculations J Mol Struct 2012 1022 49 60
   Web of Science ®Google Scholar
• Al-Abdullah ES Asiri HH El-Emam AA Ng SW Ethyl 4-{[3-(adamantan-1-yl)-4-phenyl-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-1-yl]methyl}piperazine-1-carboxylate Acta Crystallogr Sect E Struct Rep Online 2012 E68 o531
   Google Scholar
• Al-Abdullah ES Asiri HH El-Emam AA Ng SW 3-(Adamantan-1-yl)-4-phenyl-1-[(4-phenylpiperazin-1-yl)methyl]-4,5-dihydro-1H-triazole-5(4H)-thione Crystallogr Sect E Struct Rep Online 2012 E68 o345
   Google Scholar
• Al-Abdullah ES Asiri HH El-Emam AA Ng SW 3-(Adamantan-1-yl)-4-phenyl-1-[(4-benzylpiperazin-1-yl)methyl]-4,5-dihydro-1H-triazole-5(4H)-thione Crystallogr Sect E Struct Rep Online 2012 E68 o344
   Google Scholar
• Sarvá MC Romeo G Guerrera F [1,2,4]Triazole derivatives as 5-HT1A serotonin receptor ligands Bioorg Med Chem 2001 10 313 323 11741780
   PubMed Web of Science ®Google Scholar
• Alam MM Nazreen S Haider S Synthesis of some new S-alkylated 1,2,4-triazoles, their Mannich bases and their biological activities Arch Pharm (Weinheim) 2012 345 203 214 22045469
   PubMed Web of Science ®Google Scholar
• Fun HK Yeap CS Prasad KDJ Poojary B N-(2-Chlorophenyl)-2-({5-[4-(methysulfanyl)benzyl]-4-phenyl-4H-1,2,4-triazol-3-yl}sulfanyl) acetamide Crystallogr Sect E Struct Rep Online 2011 E67 o2063
   Google Scholar
• Fun HK Asik SIJ Chandrakantha B Isloor AM Shetty P 4-(4-bromophenyl)-1-(2,6-difluorobenzyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-5(4H)-thione Crystallogr Sect E Struct Rep Online 2011 E67 o3422 o3423
   Google Scholar
• El-Emam AA Lahsasni S Asiri HH Quah CK Fun HK 2-{[5-(Adamantan-1-yl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl}-N,N-dimethyl-ethanamine Crystallogr Sect E Struct Rep Online 2012 E68 o1356
   Google Scholar
• El-Emam AA Al-Abdullah ES Asiri HH Chantrapromma S Fun HK 5-(Adamantan-1-yl)-3-[(2-methoxyethyl)sulfanyl]-4-phenyl-4H-1,2,4-triazole Crystallogr Sect E Struct Rep Online 2012 E68 o2326
   Google Scholar
• Woods GL Washington JA Antibacterial susceptibility tests: dilution and disk diffusion methods Murray PR Baron EJ Pfaller MA Tenover FC Yolken RH Manual of Clinical Microbiology Washington, DC, USA American Society of Microbiology 1995
   Google Scholar
• National Committee for Clinical Laboratory Standards Approved standard document M-7A Villanova, PA, USA National Committee for Clinical Laboratory Standards 1985
   Google Scholar
• Winter CA Risely EA Nuss GW Carrageenin-induced paw oedema in hind paw of the rat as an assay for anti-inflammatory drugs Proc Soc Exp Biol Med 1962 111 544 457 14001233
   PubMed Web of Science ®Google Scholar
• Litchfield JT Wilcoxon T A simplified method of evaluating dose-effect experiments J Pharmacol Exp Ther 1949 96 99 104 18152921
   PubMed Web of Science ®Google Scholar
• Hichens M Scherrier RA Whitehouse MW Anti-Inflammatory Agents II Academic Press New York, NY, USA 1974
   Google Scholar